Sinopharm Tech Holdings Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
For the nine months, sales was HKD 19.75 million compared to HKD 37.93 million a year ago. Net income was HKD 9.09 million compared to net loss of HKD 23.41 million a year ago. Basic earnings per share from continuing operations was HKD 0.05 compared to basic loss per share from continuing operations of HKD 0.13 a year ago.